# Thiago Cerqueira‐Silva

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/thiago-cerqueira-silva/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,438 |
| Field | SARS-CoV-2 and COVID-19 Research |
| h-index | 18 |
| i10-index | 31 |
| Last Known Institution | Escola Bahiana de Medicina e Saúde Pública |
| OpenAlex ID | https://openalex.org/A5010814212 |
| ORCID iD | 0000-0003-4534-2509 |
| Works | 135 |

## Researcher papers

- [Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil](https://scholariq.org/papers/vaccine-effectiveness-of-heterologous-coronavac-plus-bnt162b2-in-brazil/)
- [Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial](https://scholariq.org/papers/efficacy-of-brazilian-green-propolis-epp-af-as-an-adjunct-treatment-for/)
- [Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study](https://scholariq.org/papers/influence-of-age-on-the-effectiveness-and-duration-of-protection-of-vaxzevria/)
- [w4200431335](https://scholariq.org/papers/w4200431335/)
- [Pathophysiology of chikungunya virus infection associated with fatal outcomes](https://scholariq.org/papers/pathophysiology-of-chikungunya-virus-infection-associated-with-fatal-outcomes/)
- [Risk of death following chikungunya virus disease in the 100 Million Brazilian Cohort, 2015–18: a matched cohort study and self-controlled case series](https://scholariq.org/papers/risk-of-death-following-chikungunya-virus-disease-in-the-100-million-brazilian/)
- [Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study](https://scholariq.org/papers/vaccine-effectiveness-of-two-dose-bnt162b2-against-symptomatic-and-severe-covid/)
- [Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period](https://scholariq.org/papers/vaccine-effectiveness-of-coronavac-against-covid-19-among-children-in-brazil/)
- [Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil](https://scholariq.org/papers/duration-of-protection-of-coronavac-plus-heterologous-bnt162b2-booster-in-the/)
- [Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group](https://scholariq.org/papers/prevalence-and-risk-factors-for-long-covid-after-mild-disease-a-cohort-study/)
- [Alpha-lipoic acid does not improve olfactory training results in olfactory loss due to COVID-19: a double-blind randomized trial](https://scholariq.org/papers/alpha-lipoic-acid-does-not-improve-olfactory-training-results-in-olfactory-loss/)

## Researcher topics

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Vaccine Coverage and Hesitancy](https://scholariq.org/topics/vaccine-coverage-and-hesitancy/)
- [Mosquito-borne diseases and control](https://scholariq.org/topics/mosquito-borne-diseases-and-control/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [COVID-19 epidemiological studies](https://scholariq.org/topics/covid-19-epidemiological-studies/)

## Researcher university

- [Escola Bahiana de Medicina e Saúde Pública](https://scholariq.org/institutions/escola-bahiana-de-medicina-e-saude-publica/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.